FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
FocalTherics (Nasdaq: FOCL) announced that CEO Ryan Rhodes will present at the H.C.
Rhea-AI Summary
FocalTherics (Nasdaq: FOCL) announced that CEO Ryan Rhodes will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York, held September 14-16, 2026. The company’s presentation is scheduled for Tuesday, September 15, 2026, from 10:30-11:00 AM ET and will be webcast live.
Rhodes and CFO Ken Mobeck will also host 1x1 investor meetings on September 15-16, 2026. A live and archived webcast of the presentation will be available via the provided conference link and through the Investors section of FocalTherics’ website.
Positive
- None.
Negative
- None.
News Market Reaction – FOCL
In the Sep 1 session, FOCL gained 0.70%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 13 | Q2 earnings report | Positive | +2.6% | Revenue growth, improved gross margin, reiterated 2026 guidance, and expanded system installations |
| Aug 11 | Public offering pricing | Negative | -21.0% | Company priced an underwritten ADS offering targeting approximately $40.0 million gross proceeds |
| Aug 11 | Preliminary Q2 results | Negative | -21.0% | Preliminary results accompanied segment reclassification and a reported strategic operating shift |
| Aug 11 | Proposed public offering | Negative | -21.0% | Company proposed an underwritten ADS offering for operating and general corporate purposes |
| Jul 30 | Q2 earnings scheduling | Neutral | -0.3% | Company scheduled release of second-quarter financial results and conference call |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical offering and preliminary-results announcements accompanied 24-hour declines of 20.97%, while the reported Q2 results accompanied a 2.59% gain.
Key Terms
robotic focal therapy medical
1x1 investor meetings financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Company to Present and Host 1x1 Investor Meetings on Tuesday and Wednesday, September 15th-16th, 2026
AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 in New York, New York. Rhodes, together with Ken Mobeck, Chief Financial Officer, will also host 1x1 investor meetings at the conference on Tuesday and Wednesday, September 15-16, 2026.
Date: Tuesday, September 15, 2026
Time: 10:30-11:00 AM ET
Format: Presentation
Webcast: https://journey.ct.events/view/678a5096-f9a4-4a67-b503-ad650aca3c59
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About FocalTherics
A recognized global leader in robotic focal therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One® Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life.
Investor Contact
Louisa Smith
Gilmartin Group
Investor.relations@focalone.com
